Metacognition in schizophrenia disorders: Comparisons with community controls and bipolar disorder: Replication with a Spanish language Chilean sample.

Autor: Lysaker PH; Roudebush VA Medical Center, 1481 West 10th Street, Indianapolis, IN, USA; Indiana University School of Medicine, Department of Psychiatry, Goodman Hall 355W. 16th St., Suite 4800, Indianapolis, IN 46202, USA. Electronic address: plysaker@iupui.edu., Irarrázaval L; Section Phenomenological Psychopathology and Psychotherapy, Psychiatric Department, Heidelberg University Hospital, Heidelberg, Germany. Voss-Str.4, D-69115, Heidelberg, Germany., Gagen EC; University of North Carolina at Chapel Hill, Department of Psychology and Neuroscience, Campus Box #3270, 235 E. Cameron Avenue, Chapel Hill, NC, Chapel Hill, NC 27599, USA., Armijo I; Faculty of Psychology, Universidad Gabriela Mistral, Av. Ricardo Lyon 1177, Providencia, Santiago 7510549, Chile., Ballerini M; 'D. Portales' University, Santiago, Chile., Mancini M; Department of Psychological, Humanistic and Territorial Sciences, University 'G. d'Annunzio', Chieti, Italy., Stanghellini G; Department of Psychological, Humanistic and Territorial Sciences, University 'G. d'Annunzio', Chieti, Italy; 'D. Portales' University, Santiago, Chile.
Jazyk: angličtina
Zdroj: Psychiatry research [Psychiatry Res] 2018 Sep; Vol. 267, pp. 528-534. Date of Electronic Publication: 2018 Jun 21.
DOI: 10.1016/j.psychres.2018.06.049
Abstrakt: Metacognition refers to the activities which allow for the availability of a sense of oneself and others in the moment. Research mostly in North America with English-speaking samples has suggested that metacognitive deficits are present in schizophrenia and are closely tied to negative symptoms. Thus, replication is needed in other cultures and groups. The present study accordingly sought to replicate these findings in a Spanish speaking sample from Chile. Metacognition and symptoms were assessed among 26 patients with schizophrenia, 26 with bipolar disorder and 36 community members without serious mental illness. ANCOVA controlling for age and education revealed that the schizophrenia group had greater levels of metacognitive deficits than the bipolar disorder and community control groups. Differences in metacognition between the clinical groups persisted after controlling for symptom levels. Spearman correlations revealed a unique pattern of associations of metacognition with negative and cognitive symptoms. Results largely support previous findings and provide added evidence of the metacognitive deficits present in schizophrenia and the link to outcome cross culturally. Implications for developing metacognitively oriented interventions are discussed.
(Published by Elsevier B.V.)
Databáze: MEDLINE
Externí odkaz: